[1] 吕春燕,时淑燕,杨玲,等.842例肾手术患者临床病理及流行病学研究[J].西部医学,2016,28(2):208-211.[2] Yasuda H,Tochigi Y,Katayama K,et al.Progression of renal fibrosis in congenital CKD model rats with reduced number of nephrons.Exp Toxicol Pathol.2017.pii: S0940-2993(16)30302-5. doi: 10.1016/j.etp.2017.01.007. [Epub ahead of print][3] 唐秀容,吕春燕,杨天林,等.慢性不全梗阻性无功能肾临床病理特征及CD44表达情况[J].吉林医学,2016,37(10):2389-2391.[4] Tian S,Li C,Ran R,et al.Surfactant protein A deficiency exacerbates renal interstitial fibrosis following obstructive injury in mice.Biochim Biophys Acta.2017;1863(2):509-517.[5] Baba A,Tachi M,Ejima Y,et al.Less contribution of mast cells to the progression of renal fibrosis in Rat kidneys with chronic renal failure.Nephrology(Carlton).2017;22(2):159-167.[6] Liu M,Ning X,Li R,et al.Signalling pathways involved in hypoxia-induced renal fibrosis.J Cell Mol Med.2017;1:1-12.[7] Yang B,Chen S,Wu M,et al.PHF14: an innate inhibitor against the progression of renal fibrosis following folic acid-induced kidney injury.Sci Rep.2017;3(7):39888.[8] Pefanis A,Botlero R,Langham RG,et al.eMAP:CKD: electronic diagnosis and management assistance to primary care in chronic kidney disease.Nephrol Dial Transplant.2016. pii: gfw366. [Epub ahead of print][9] Wyld MLR,Lee CMY,Zhuo X,et al.Cost to government and society of chronic kidney disease stage 1–5: a national cohort study.Intern Med J.2015;45:741-747.[10] Li Z,Liu X,Wang B,et al. Pirfenidone suppresses MAPK signaling pathway to reverse epithelial-mesenchymal transition and renalfibrosis.Nephrology (Carlton).2016;7: 12831. [11] Keshk WA,Katary MA.Transforming Growth Factor-β1/Smad3 Signaling and Redox Status in Experimentally Induced Nephrotoxicity: Impact of Carnosine.Indian J Clin Biochem. 2017;32(1):19-25.[12] JYu JW,Duan WJ,Huang XR,et al.MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis.Lab Invest.2014;94(9):978-990.[13] 吕春燕,李娟.干细胞治疗梗阻性肾病:研究现状与存在问题[J].中国组织工程研究,2014,18(50):8184-8188.[14] Song Y,Peng C,Lv S,et al. Adipose-derived stem cells ameliorate renal interstitial fibrosis through inhibition of EMT and inflammatory response via TGF-β1 signaling pathway.Int Immunopharmacol.2017;44:115-122.[15] 吕春燕,陈高莉,杨玲,等.大鼠脂肪干细胞分离培养及细胞表型的研究[J].海南医学,2014,25(9):1256-1259.[16] Radford MG,Donadio JV,Bergstral HE,et al.Predicting renal outcome in IgA nephropathy.Jan Soc Nephrol.1997;8(2):199.[17] Mizuguchi Y,Miyajima A,Kosaka T,et al.Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction.Urol.2004;172(6 Pt 1):2456.[18] Zhou G,Johansson U,Peng XR,et al.An additive effect of eplerenone to ACE inhibitor on slowing the progression of diabetic nephropathy in the db/db mice.Am J Transl Res. 2016;8(3):1339-1354.[19] Sun N,Zhai L,Li H,et al.Angiotensin-Converting Enzyme Inhibitor (ACEI)-Mediated Amelioration in Renal Fibrosis Involves Suppression of Mast Cell Degranulation. Kidney Blood Press Res.2016;41(1):108-118.[20] Callera GE,Antunes TT,Correa JW,et al.Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.Biosci Rep. 2016;36(5):e00398.[21] Zhou G,Liu X,Cheung AK,et al.Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?Am J Transl Res.2015;7(5):825-840.[22] Chen HY,Zhong X,Huang XR,et al. MicroRNA-29b inhibits diabetic nephropathy in db/db mice[.Mol Ther.2014;22(4): 842-853.[23] 陈昌金,杨雪梅,吕春燕,等.损伤性肾匀浆体外诱导大鼠骨髓间充质干细胞转分化效果及可能机制的研究[J].重庆医学,2016, 45(3): 299-302.[24] Eliasberg CD,Dar A,Jensen AR,et al.Perivascular Stem Cells Diminish Muscle Atrophy Following Massive Rotator Cuff Tears in a Small Animal Model.J Bone Joint Surg Am. 2017; 99(4):331-341.[25] 岳荣川,廖翔,王伟,等.心肌球源性干细胞对急性心肌梗死的治疗作用及机制[J].西部医学,2016,28(3):325-329.[26] 陈昌金,袁惠,辜海英,等.多效生长因子基因转染小鼠脂肪来源干细胞的实验研究[J].中国修复重建外科杂志,2013,27(8): 897-901.[27] 孙晓婷,邹春林.上皮间质转化在糖尿病肾病肾间质纤维化中的研究进展[J].中国糖尿病杂志,2016,24(7):655-661.[28] 刘珊,王惠明,丁国华.上皮间质转化在肾脏纤维化中的分子机制研究进展[J].临床内科杂志,2016,33(6):428-430.[29] 李晓东,李胤祺.乙醛促进人肾小管上皮细胞表型变化并增加细胞α平滑肌肌动蛋白的表达[J].细胞与分子免疫学杂志,2016, 32(2):221-223.[30] 王倩,赵向娅,杨轶,等.sEH抑制剂在小鼠单侧输尿管梗阻模型中的保护作用及机制[J].中华肾脏病杂志,2016,32(6):436-443. |